Regi Vengalil - Jun 8, 2024 Form 4 Insider Report for Porch Group, Inc. (PRCH)

Role
Director
Signature
/s/Matthew Cullen as Attorney-in-fact for Regi Vengalil
Stock symbol
PRCH
Transactions as of
Jun 8, 2024
Transactions value $
$0
Form type
4
Date filed
6/11/2024, 07:07 PM
Previous filing
Jun 12, 2023
Next filing
Jun 14, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRCH Common Stock Award $0 +70.1K +53.47% $0.00 201K Jun 8, 2024 Direct F1
transaction PRCH Common Stock Other $0 -89.5K -44.5% $0.00 112K Jun 8, 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an annual grant of fully vested restricted stock units ("RSUs") for Board and Committee service under the Issuer's Non-Employee Director Compensation Policy (the "Policy"). The RSUs were granted to correct the previously reported June 8, 2023 annual grant of RSUs, pursuant to which the Reporting Person was not granted the appropriate number of RSUs under the Policy. In addition, the RSUs were granted fully vested on June 8, 2024 in order to make such correction as of the applicable vesting date for the previously reported 2023 annual grant. Each RSU represents a right to receive one share of the Issuer's common stock upon vesting. The common stock will have resale restrictions pursuant to which two-thirds of the common stock may not be sold after June 8, 2024. The resale restrictions expire in equal increments on the first and second anniversaries of June 8, 2024. See Footnote 2 for a related cancellation of the previously reported 2023 annual grant.
F2 Represents the cancellation of the previously reported 2023 annual grant for Board and Committee service under the Policy. The shares are being cancelled without value to correct the previously reported 2023 annual grant, pursuant to which the Reporting Person was not granted the appropriate number of RSUs under the Policy.